Evaluation of haematuria (visible and non-visible)
haematuria · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Structured work-up distinguishing glomerular (nephrological) from urological bleeding and identifying malignancy, stones or infection. Visible haematuria and non-visible haematuria with risk factors warrant prompt urological assessment; glomerular patterns go to nephrology.
Red flags
- Visible haematuria with clots (urological malignancy until excluded)
- Haematuria with weight loss, flank mass or bone pain
- Red cell casts/dysmorphic cells with rising creatinine (glomerulonephritis)
- Haematuria with fever and loin pain (infected obstruction)
- New proteinuria with haematuria
Assessment
Differential diagnosis
- Urological malignancy (bladder, renal, prostate)
- Urinary tract infection
- Nephrolithiasis
- Glomerular disease (IgA nephropathy, thin GBM, Alport)
- BPH / urethral/prostatic bleeding
- Exercise-induced or menstrual contamination
Investigations
- Urinalysis and microscopy (dysmorphic RBCs, red cell casts, proteinuria)
- Urine culture (exclude infection) and repeat dipstick after treating UTI
- Urine ACR/PCR and renal function
- Blood pressure
- Renal tract imaging (ultrasound or CT urogram) per risk
- Flexible cystoscopy for visible haematuria or high-risk non-visible haematuria
Management
- Confirm true haematuria (positive dipstick with red cells on microscopy; exclude myoglobin/haemoglobin and contamination)
- Treat and recheck if urinary tract infection is present
- Classify as visible or non-visible (symptomatic vs asymptomatic) haematuria
- Look for glomerular clues: dysmorphic red cells, red cell casts, proteinuria, hypertension, impaired function
- Refer all visible haematuria (without clear infective cause) and high-risk non-visible haematuria for urological assessment including cystoscopy and upper-tract imaging
- Refer patients with glomerular features (proteinuria, casts, raised creatinine) to nephrology
- Use CT urogram for upper-tract imaging where malignancy risk is higher (age, smoking)
- Investigate and manage identified stones, tumours or infection appropriately
- For isolated non-visible haematuria without glomerular or urological cause, monitor BP, eGFR and ACR periodically
- Address cardiovascular and renal risk in persistent glomerular haematuria
- Reassess if proteinuria or function changes over time
- Document a clear surveillance or discharge plan
Drugs & doses
Culture-directed antibiotics for confirmed UTI (e.g. nitrofurantoin 100 mg MR PO twice daily for 3-7 days)
ACE inhibitor/ARB if glomerular haematuria with proteinuria/hypertension (e.g. ramipril 2.5-10 mg PO daily)
Disposition
Urology referral for visible/high-risk haematuria (two-week-wait pathways where cancer suspected); nephrology for glomerular patterns. Monitor isolated benign non-visible haematuria in primary care.
Complications & pitfalls
- Missed urological malignancy
- Progressive glomerular disease if nephrological cause overlooked
- Anaemia from significant bleeding/clot retention
- Obstruction from clots
- Delayed diagnosis from attributing to anticoagulation alone
Exam pearls
- Dysmorphic red cells and red cell casts point to a glomerular (nephrology) cause
- Visible haematuria needs urological work-up even if the patient is anticoagulated — do not just blame the warfarin
- Always exclude and re-test after UTI before extensive work-up
- Proteinuria alongside haematuria raises the chance of significant glomerular disease
- Smoking and age raise urothelial cancer risk — lower the threshold for cystoscopy/CT urogram
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.